Samil Pharmaceutical Co.,Ltd (KRX:000520)

KRX:000520 Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 23, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	203,592	205,715	279,170	96,901	108,894	106,418
Market Cap Growth	-15.51%	-26.31%	188.10%	-11.01%	2.33%	-17.45%
Enterprise Value	361,204	363,668	420,498	272,367	265,842	202,048
Last Close Price	9590.00	9690.00	13150.00	6700.00	7800.00	7509.09
PE Ratio	-	-	-	58.25	-	-
PS Ratio	0.97	0.98	1.27	0.49	0.61	0.79
PB Ratio	1.53	1.54	1.59	0.76	0.87	1.62
P/TBV Ratio	1.57	1.59	1.63	0.77	0.89	1.65
P/OCF Ratio	358.33	362.07	107.79	8.25	26.22	75.11
EV/Sales Ratio	1.72	1.73	1.91	1.39	1.48	1.51
EV/EBITDA Ratio	-	-	57.52	23.03	29.52	39.53
EV/EBIT Ratio	-	-	8739.66	42.16	66.19	505.45
Debt / Equity Ratio	1.23	1.23	0.85	1.38	1.27	1.91
Debt / EBITDA Ratio	-	-	20.53	14.87	17.68	24.55
Net Debt / Equity Ratio	1.18	1.18	0.82	1.37	1.25	1.68
Net Debt / EBITDA Ratio	-10.69	-10.69	19.83	14.79	17.47	21.57
Net Debt / FCF Ratio	-22.88	-22.88	-52.11	-14.00	-3.55	-3.51
Asset Turnover	0.55	0.55	0.57	0.54	0.62	0.64
Inventory Turnover	3.83	3.83	4.13	4.27	4.59	3.53
Quick Ratio	0.23	0.23	0.38	0.22	0.27	0.38
Current Ratio	0.44	0.44	0.86	0.48	0.56	0.63
Return on Equity (ROE)	-22.41%	-22.41%	-3.70%	1.31%	-0.03%	-8.27%
Return on Assets (ROA)	-3.90%	-3.90%	0.01%	1.11%	0.86%	0.12%
Return on Invested Capital (ROIC)	-8.09%	-7.82%	0.01%	2.21%	-0.05%	0.25%
Return on Capital Employed (ROCE)	-12.80%	-12.80%	0.00%	3.20%	1.80%	0.40%
Earnings Yield	-17.03%	-16.85%	-2.02%	1.72%	-0.03%	-5.02%
FCF Yield	-3.38%	-3.35%	-1.00%	-12.90%	-40.71%	-29.52%
Buyback Yield / Dilution	-18.05%	-18.05%	-24.32%	-3.75%	-0.82%	-2.85%
Total Shareholder Return	-18.05%	-18.05%	-24.32%	-3.75%	-0.82%	-2.85%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.